VERO (Venus Concept Corp) Short-Term Debt to Capital

Venus Concept Corporation - graphic logo of issuer VERO

Market fluctuations in Venus Concept Inc. (VERO) shares reflect the dynamics of a company producing aesthetic devices with an extensive supply network, where warehouse diversification ensures stable exports. The current indicator stands at 0.00, while margin growth is driven by robotic liposuction systems and the restructuring of liabilities. Management is currently overseeing the update of the contract manufacturer pool to prevent equipment shipment disruptions.

Ratio of Short-Term Indebtedness to Capital: Venus Concept Inc (VERO) for 07/04/2022 - 02/21/2026
Signature product of venusconcept.com

For Venus Concept Inc. (VERO), which utilizes an equipment subscription model to ensure recurring revenue, monitoring the ratio of short-term loans to equity is critical for assessing liquidity risks. By analyzing the change in short-term liabilities relative to capital, an investor determines the company's ability to settle debts due within one year without cash flow gaps, confirming the financial strategy stability of this aesthetic medicine leader.

Analysis of competing companies

Short-Term Debt to Capital DXCM|PEN (Penumbra Medical) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital NOVT (Novanta Inc.)|haemonetics.com (HAE) - Current Liabilities to Capital|INSP - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PRCT (PROCEPT BioRobotics Corp)|CNMD: Short-Term Debt to Capital|Pulse Medical (PLSE) - Short-Term Debt to Capital|Short-Term Debt to Equity InMode Ltd.|picardmedical.com - Current Liabilities to Equity|Short-Term Debt to Capital SRDX|SENS - Current Liabilities to Capital|NeuroPace Corp - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tactile Systems Technology, Inc. TCMD|SNWV: Short-Term Debt to Equity Ratio|outsetmedical.com - Short-Term Loans to Capital Ratio|ELMD: Short-Term Debt to Capital|LNSR - Short-Term Debt to Capital Coefficient|RCEL (AVITA Medical, Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Profound Medical Corporation (PROF)|Short-Term Debt to Equity Ratio BDMD (Baird Medical Investment)|EDAP (edap-tms.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Apyx Medical Corporation APYX|ICCM - Short-Term Debt to Equity Ratio|Pulmonx Corp. - Short-Term Debt to Capital|Current Liabilities to Capital TELA Bio, Inc.|CTSO: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SRTS|ZYXI (Zynex) - Short-Term Debt to Capital|electroCore Medical (ECOR) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital RBOT|Short-Term Debt to Equity Ratio inspira-technologies.com IINN|Short-Term Debt to Capital ICU (SeaStar Medical Holding)|Short-Term Debt to Capital IRIDEX Corp IRIX|INBS - Short-Term Debt to Equity|XAIR: Short-Term Debt to Equity|PFSA (Profusa, Inc.) - Short-Term Debt to Equity Ratio|STRATA Skin Sciences, Inc. - Ratio of Short-Term Indebtedness to Capital|GCTK (GlucoTrack, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital nanovibronix.com NAOV|Short-Term Debt to Equity Nuwellis (NUWE)|Aethlon Medical Inc (AEMD) - Short-Term Indebtedness to Equity|Asensus Surgical - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Avinger Inc AVGR|BioSig - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient cutera.com CUTR|Know Labs (KNW) - Short-Term Debt to Equity|Current Liabilities to Equity NARI (Inari Medical Inc)|Short-Term Debt to Equity Nevro Corporation|Short-Term Debt to Equity Ratio ReShape Lifesciences Inc (RSLS)|Short-Term Debt to Capital SILK